100
Participants
Start Date
October 9, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
February 28, 2025
COPD Optimiser
Patients will receive enhanced usual medical care as determined by their physician. The study visit is a standard consultation supported by the COPD Optimiser webtool. The extra elements added to the COPD consultation are the use of the COPD Optimiser and a short questionnaire directly following the consultation on the patient's experience with the COPD Optimiser. Patients can additionally consent to two optional elements: 1) a determination of blood eosinophil count using a point of care test and 2) a brief interview on their experience with the COPD Optimiser. this tool creates an overview of fac- tors and characteristics that may be associated with suboptimal COPD and provides GOLD guideline-based management suggestions. Implementation of the COPD Optimiser will sup- port healthcare professionals in providing optimal care for their COPD patients by providing individualized GOLD-guided management suggestions.
General practices in Netherlands, Groningen
GPRI, Groningen
Lead Sponsor
Collaborators (1)
AstraZeneca
INDUSTRY
General Practitioners Research Institute
NETWORK